THE SCHEDULE 13G

Company

RELMADA THERAPEUTICS, INC.

Filed

December 20, 2021

Accession Number

0000921895-21-002878

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →